Literature DB >> 12536358

GnRH agonists, antagonists, and assisted conception.

André C D van Loenen1, Judith A F Huirne, Roel Schats, Peter G A Hompes, Cornelis B Lambalk.   

Abstract

Pituitary stimulation with pulsatile gonadotropin-releasing hormone (GnRH) induces both follicle-stimulating hormone and luteinizing hormone (LH). Blockade of pituitary gonadotropin secretion occurs upon desensitization when a continuous GnRH stimulus is provided by means an agonist or when the pituitary receptors are occupied with a competitive antagonist. The most common indication for blockade of pituitary gonadotropin secretion is with assisted reproduction treatment (ART) where it prevents premature luteinization. Originally by lack of clinically available GnRH antagonist, prolonged daily injection of agonist with its desensitizing effect was introduced for this purpose. Today, single- and multiple-dose injectable antagonists are also available to block the LH surge. This review provides an overview of the use of GnRH agonists and antagonists in assisted reproduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536358     DOI: 10.1055/s-2002-36713

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  14 in total

1.  Comparison of single-agent androgen suppression for advanced prostate cancer.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

2.  Androgen deprivation therapy in the treatment of advanced prostate cancer.

Authors:  Mark A Perlmutter; Herbert Lepor
Journal:  Rev Urol       Date:  2007

Review 3.  Comparison of different stimulation protocols used in in vitro fertilization: a review.

Authors:  Deekshya Shrestha; Xiaolin La; Huai L Feng
Journal:  Ann Transl Med       Date:  2015-06

4.  Microdose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization?

Authors:  Eric D Levens; Brian W Whitcomb; Jonathan D Kort; Donna Materia-Hoover; Frederick W Larsen
Journal:  Fertil Steril       Date:  2008-02-04       Impact factor: 7.329

5.  Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization.

Authors:  Xiuxian Zhu; Xiaole Zhang; Yonglun Fu
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Comparison of neonatal outcomes following progesterone use during ovarian stimulation with frozen-thawed embryo transfer.

Authors:  Xiuxian Zhu; Hongjuan Ye; Yonglun Fu
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

7.  The ovulation trigger-OPU time interval of different ovarian protocols in ART: a retrospective study.

Authors:  Xi Shen; Hui Long; Wenya Guo; Yating Xie; Hongyuan Gao; Jie Zhang; Yun Wang; Qifeng Lyu; Yanping Kuang; Li Wang
Journal:  Arch Gynecol Obstet       Date:  2020-06-03       Impact factor: 2.344

8.  Nimodipine, a calcium channel blocker, delays the spontaneous LH surge in women with regular menstrual cycles: a prospective pilot study.

Authors:  Dan Nayot; Shany Klachook; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2013-02-07       Impact factor: 5.211

9.  Leuprorelin depot injection: patient considerations in the management of prostatic cancer.

Authors:  Zinelabidine Abouelfadel; E David Crawford
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 10.  Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer.

Authors:  John Zhang
Journal:  Int J Fertil Steril       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.